Mike A. Scott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mike A. Scott has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Anthony J. Bench
Department of Haematology, Haemato-Oncology Diagnostic Service, Addenbrooke’s Hospital
1 shared publicationDavid M. Bloxham
Department of Haematology, Haemato-Oncology Diagnostic Service, Addenbrooke’s Hospital
1 shared publicationElaine M. Boyd
Department of Haematology, Haemato-Oncology Diagnostic Service, Addenbrooke's Hospital Department of Histopathology, Addenbrooke's Hospital, Cambridge, UK
1 shared publicationGeorge A. Follows
Department of Haematology, Haemato-Oncology Diagnostic Service, Addenbrooke’s Hospital
1 shared publication- Joseph Padayatty
Department of Haematology, Addenbrooke's Hospital, Cambridge, UK
1 shared publication Mars B. Van'T Veer
Department of Haematology; Box 234, Addenbrooke's Hospital; Cambridge; UK
1 shared publication
Latest Publications
- 17 August 2012
- Published by Wiley in European Journal of Haematology
- Vol. 89 (5) , 435
EDTA and temperature dependent neutrophil aggregation
- 17 August 2012
- Published by Wiley in European Journal of Haematology
- Vol. 89 (5) , 435
EDTA and temperature dependent neutrophil aggregation
- Open Access
- 13 September 2011
- Published by Wiley in British Journal of Haematology
- Vol. 155 (5) , 609-612
High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies
Summary: The BRAF V600E mutation has recently been described in all cases of hairy cell leukaemia (HCL). We have developed and validated a rapid and sensitive high‐resolution melting analysis (HRMA) assay that detects BRAF exon 15 mutations when hairy cells are as low as 5–10% in a sample. All 48 HCL patients were positive for the BRAF V600E mutation, while 114 non‐HCL cases were all V600E negative. Interestingly, we detected a novel BRAF D594N mutation in one patient with multiple myeloma. The HRMA assay offers a useful tool to aid the laboratory diagnosis of HCL.
- 13 September 2011
- Published by Wiley in British Journal of Haematology
- Vol. 155 (5) , 609-612
Open AccessHigh resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies
Summary: The BRAF V600E mutation has recently been described in all cases of hairy cell leukaemia (HCL). We have developed and validated a rapid and sensitive high‐resolution melting analysis (HRMA) assay that detects BRAF exon 15 mutations when hairy cells are as low as 5–10% in a sample. All 48 HCL patients were positive for the BRAF V600E mutation, while 114 non‐HCL cases were all V600E negative. Interestingly, we detected a novel BRAF D594N mutation in one patient with multiple myeloma. The HRMA assay offers a useful tool to aid the laboratory diagnosis of HCL.